Global High-density Multiplexed Diagnostic Assays Market
WiseGuyRerports.com Presents “Global High-density Multiplexed Diagnostic Assays Market 2017-2021” New Document to its Studies Database. The Report Contain 89 Pages With Detailed Analysis.
Description
A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed in the laboratory, pharmacology, molecular biology, and various other medical procedures. Different types of assays are performed for the detection and diagnosis of patient’s sample.
The analysts forecast the global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global high density multiplexed diagnostic assays market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
Get sample Report @ https://www.wiseguyreports.com/sample-request/1482538-global-high-density-multiplexed-diagnostic-assays-market-2017-2021
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
The Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Thermo Fisher Scientific
• Abbott
• F. Hoffmann-La Roche
Other prominent vendors
• Agilent Technologies
• Bio-Rad Laboratories
• Erba Diagnostics
• GOLD STANDARD DIAGNOSTICS
• Hologic
• Luminex
• Randox Laboratories
Market driver
• Increasing equipment rental agreements
• For a full, detailed list, view our report
Market challenge
• High cost of multiplexed diagnostic assay equipment
• For a full, detailed list, view our report
Market trend
• Introduction of automated multiplexed PCR assays
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/1482538-global-high-density-multiplexed-diagnostic-assays-market-2017-2021
Table of Contents -Major Key Points
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• High-density multiplexed diagnostic assays (500-10,000 plex)
• Very high-density multiplexed diagnostic assays (>10,000 plex)
• Market overview
PART 07: Market segmentation by end-user
• Market overview
• Clinical diagnostic laboratories
• Hospitals and clinics
PART 08: Geographical segmentation
• High-density multiplexed diagnostic assays market in Americas
• High-density multiplexed diagnostic assays market in EMEA
• High-density multiplexed diagnostic assays market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Infectious diseases
• Oncology
• Autoimmune diseases
• Cardiac diseases
• Allergies
• Other application areas
• Market challenges
PART 11: Market trends
• Introduction of automated multiplexed PCR assays
• Higher adoption rate of molecular POCT
• Improved sensitivity for the detection systems
• Outsourcing from hospitals to reference laboratories
PART 12: Vendor landscape
• Competitive landscape analysis
PART 13: Key vendor analysis
• Thermo Fisher Scientific
• Abbott
• F. Hoffmann-La Roche
• Key companies to watch
• Other prominent vendors
……..CONTINUED